Clinical Trial

Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa

Withdrawn Phase 2
View on ClinicalTrials.gov →
Why the trial stopped
no participants enrolled
Summary
Sinonasal mucosal malignant melanoma (SNMM) is a nasal and paranasal sinus malignancy with a low incidence and extremely poor prognosis, exhibiting specificity in Asian populations. For resectable SNMM, the efficacy of neoadjuvant immunotherapy is unclear. This prospective clinical study aims to explore the survival prognosis of neoadjuvant immunotherapy combing radiochemotherapy after Endoscopic Surgery for resectable SNMM.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Withdrawn 2026-07-11
critical Reason stopped changed: — → no participants enrolled 2026-07-11
notable Enrollment reduced: 25 -> 0 participants 2026-07-11
Trial Details
NCT Number NCT07614828
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Huadong Hospital
Conditions Mucosal Melanoma of the Head and Neck
Start Date 2023-06-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-10